Also trades as: CHG.BK (SET) · $vol 2M
CHG-R.BK SET
Chularat Hospital Public Company Limited
1W: -3.8%
1M: -2.6%
3M: -5.0%
YTD: -7.9%
1Y: -16.0%
3Y: -44.1%
฿1.52 ($0.05)
-0.01 (-0.65%)
Weekly Expected Move ±3.1%
฿1
฿1
฿2
฿2
฿2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$8.3B
+1.3% ▲
5Y CAGR: +9.0%
Gross Profit
$2.4B
+9.0% ▲
5Y CAGR: +6.2%
Operating Income
$1.2B
-8.1% ▼
5Y CAGR: +1.4%
Net Income
$929M
-3.7% ▼
5Y CAGR: +1.2%
EPS (Diluted)
$0.08
-3.6% ▼
5Y CAGR: +1.2%
EBITDA
$1.7B
-5.0% ▼
5Y CAGR: +2.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $11.7B | $10.1B | $7.7B | $8.2B | $8.3B |
| YoY Growth | +116.1% | -14.0% | -23.5% | +6.6% | +1.3% |
| Cost of Revenue | $5.9B | $5.9B | $5.7B | $6.1B | $6.0B |
| Gross Profit | $5.9B | $4.2B | $2.0B | $2.2B | $2.4B |
| Gross Margin | 49.9% | 41.5% | 26.0% | 26.3% | 28.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $821M | $935M | $911M | $1.1B | $1.2B |
| Operating Expenses | $564M | $630M | $911M | $1.1B | $1.2B |
| Operating Income | $5.3B | $3.6B | $1.4B | $1.3B | $1.2B |
| Operating Margin | 45.1% | 35.3% | 17.9% | 15.6% | 14.2% |
| Interest Expense | $21M | $16M | $24M | $35M | $28M |
| Income Before Tax | $5.3B | $3.6B | $1.3B | $1.2B | $1.2B |
| Tax Expense | $1.0B | $703M | $279M | $267M | $251M |
| Net Income | $4.2B | $2.8B | $1.0B | $965M | $929M |
| Net Margin | 35.8% | 27.5% | 13.5% | 11.7% | 11.1% |
| EPS (Diluted) | $0.38 | $0.25 | $0.10 | $0.09 | $0.08 |
| EBITDA | $5.6B | $4.0B | $1.8B | $1.8B | $1.7B |
| Shares Outstanding | 11.00B | 11.00B | 11.00B | 11.00B | 11.00B |